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Background. Septal penetration causes collimator-dependent differences in the heart-to-
mediastinum (H/M) ratio in 123I-metaiodobenzylguanidine (MIBG) cardiac imaging. We
investigated generally applicable methods to correct such differences.
Methods and Results. Four hours after 123I-MIBG injection, 40 patients underwent anterior
chest imaging successively with medium-energy (ME) and various non-ME collimators. The H/
M ratios obtained with the non-ME collimators before and after 123I-dual-window penetration
correction were compared with the ME-derived standard values to determine patient-based
conversion equations for empiric and combined corrections, respectively. A 123I point source
was imaged with various collimators, and the central ratio, the ratio of count in a small central
region of interest to count in a large one, was calculated. The method of predicting the con-
version equations from the central ratios was determined. Correction using the patient-based
conversion equations removed systematic underestimation of the H/M ratios obtained with the
non-ME collimators, and combined correction depressed residual random errors to some
degree. Point-source-based equations yielded results comparable to the patient-based equations.
Conclusions. Empiric and combined corrections effectively reduce collimator-dependent
differences in the H/M ratio. The conversion equations can be predicted from simple point-source
imaging, which would allow to apply these corrections to data obtained with various collimators. (J
Nucl Cardiol 2016)
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INTRODUCTION
Cardiac sympathetic imaging with 123I-
metaiodobenzylguanidine (123I-MIBG) is used for the
assessment of disease severity and prognosis in heart
failure1 as well as for the evaluation of neurodegener-
ative disorders such as Parkinson’s disease and dementia
with Lewy bodies.2 The kinetics of 123I-MIBG in the left
ventricle reflect sympathetic innervation, and patients
with impaired cardiac sympathetic function exhibit
decreased accumulation and accelerated washout. For
quantitative assessment, the heart-to-mediastinum (H/
M) ratio, the ratio of count density in the left ventricle to
that in the upper mediastinum, is used extensively.
Collimator choice affects the estimation of the H/M
ratio greatly, which has been reviewed elsewhere.3 Low-
energy (LE) collimators are designed primarily for
imaging 99mTc sources, and are often applied to 123I
imaging. Although an LE collimator is appropriate for
159-keV primary photons of 123I, this radionuclide also
emits high-energy photons of more than 400 keV that
easily penetrate the thin septa of an LE collimator. Septal
penetration of high-energy photons degrades image qual-
ity and quantitative accuracy in 123I imaging. Medium-
energy (ME) collimators have thicker septa than LE
collimators and effectively prevent septal penetration.
The use of an ME collimator improves quantitative
accuracy in 123I imaging and provides better estimates of
H/M ratios compared with an LE collimator.4-6 However,
LE collimators are often applied to cardiac 123I-MIBG
imaging because of their wide availability.6
Septal penetration causes systematic underestima-
tion of the H/M ratios due to predominant
overestimation of the mediastinum count3 and disturbs
comparison of values obtained using different collima-
tors. To facilitate interfacility comparison and
intrafacility comparison before and after changing the
imaging protocol, methods to correct collimator-depen-
dent differences have been investigated. The triple-
energy-window method to remove the effects of scat-
tering and septal penetration failed to attain reliable
correction in previous phantom studies.4,5 In other
studies,7,8 patients were successively imaged with the
ME and non-ME collimators, and regression equations
between the H/M ratios obtained with different colli-
mators were determined. Using the regression equation,
the non-ME-derived H/M ratio was converted to an
equivalent value to be obtained with the ME collimator.
This correction method, termed empiric correction
because of the empiric determination of the conversion
equation, effectively removes systematic underestima-
tion caused by septal penetration. However, imaging
with a non-ME collimator makes estimation of the H/M
ratio susceptible to the variability of surrounding
radioactivity, and the degree of the underestimation
depends on the intensity and distribution of activity in
the liver and lung.4,9 Even after removal of systematic
underestimation by empiric correction, random errors
remain.7,8 The 123I-dual-window (IDW) correction is a
penetration correction method in which the influence of
septal penetration of high-energy photons is predicted
based on counts in a high-energy subwindow.10
Although the IDW correction alone did not yield
satisfactory results,7,8 a combined method of empiric
correction and IDW correction achieved better correc-
tion than pure empiric correction: removal of systematic
underestimation and concomitant reduction of random
errors.8
A given vendor offers collimators of various spec-
ifications, and collimators of the same name provided by
different vendors differ in actual specifications.
Although the conversion equations should depend on
detailed collimator specifications, the equation for com-
bined correction was determined only for one collimator
provided by one vendor in the previous study.8 It is
troublesome to determine the equation for each colli-
mator based on successive patient imaging. Convenient
phantom-based determination of conversion coefficients
has been proposed;11,12 however, apparent underestima-
tion remained after the correction.12 Additionally, the
method is a simple conversion like the empiric correc-
tion described above, and does not reduce random
errors.
In this study, we compared the H/M ratios obtained
with ME and various non-ME collimators in the same
patients, and determined conversion equations for
empiric correction and combined correction. Further-
more, using the results, we developed a novel method of
predicting the conversion equations from point-source
images to correct the H/M ratios obtained with colli-
mators that were not examined in this study. Our aim
was to establish generally applicable methods for
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Two dual-headed gamma camera systems were used in
this study: e.cam (Siemens, Erlangen, Germany) and Bright-
View X with XCT (Philips Medical Systems, Cleveland, OH).
The low-energy high-resolution (LEHR), low-energy all-pur-
pose (LEAP), special low-energy high-resolution (SLEHR),
low-medium-energy (LME), and ME collimators were used for
the Siemens camera, and the cardiac high-resolution (CHR)
collimator was used for the Philips camera. The specifications
of the collimators are presented in Table 1. The shape of the
hole was hexagonal in all collimators. The pixel sizes were
2.398 and 1.199 mm using 256 9 256 and 512 9 512 matri-
ces, respectively, for the Siemens camera; they were 2.332 and
1.166 mm using 256 9 256 and 512 9 512 matrices, respec-
tively, for the Philips camera. Analyses of image data,
including those obtained using the Philips camera, were
performed on an e.soft workstation (Siemens).
Point-Source Imaging
A point source of 123I was imaged with each collimator to
evaluate the degree of septal penetration. Approximately 30
MBq 123I-MIBG in 0.5-mL solution was put in a 2.5-mL
plastic syringe, which was then placed on the imaging table of
the gamma camera system, 10 cm below the center of the
detector head. The radioactivity in the plastic syringe was
measured using a dose calibrator (IGC-7; Hitachi Aloka
Medical, Tokyo, Japan) and corrected for the effect of LE
photons.13 The photopeak energy window was a 20% window
centered at 159 keV (range, 143.1-174.9 keV), and the high-
energy subwindow for IDW correction was a 50% window
centered at 235 keV (range, 176.3-293.8 keV). The matrix was
512 9 512, the zoom factor was 1, and the acquisition time
was 5 min. Background counts in the absence of radioactive
sources were measured with each collimator using the same
imaging parameters.
Small and large square regions of interest (ROIs) were set
such that the centers of the ROIs corresponded to the center of
the point source. The side length was 55 mm for the small ROI
(46 and 47 pixels for the Siemens and Philips cameras,
respectively) and 380 mm for the large ROI (317 and 326
pixels for the Siemens and Philips cameras, respectively).
After background subtraction, the central ratio, defined as the
total count in the small ROI to that in the large ROI, was
calculated before and after penetration correction by the IDW
method. The IDW-corrected count (CIDW) was calculated
using the following equation:
CIDW ¼ Cp  Cs
Ws
Wp; ð1Þ
where Cp and Cs are the total counts in the photopeak
window and subwindow, respectively, and Wp and Ws
are the widths of the photopeak window and subwindow,
respectively. For the calculation of the IDW-corrected
central ratio, both counts in the small and large ROIs
were corrected by the IDW method.
Patient Imaging
Forty patients (24 men and 16 women; mean age ± SD,
71.4 ± 9.6 years) who underwent cardiac 123I-MIBG imaging
for the evaluation of neurodegenerative disorders were
enrolled in this study. The study protocol was approved by
the institutional review board. All patients provided written
informed consent prior to participating in the study.
The patients underwent anterior planar imaging of the
chest at the early (15 min) and late (4 h) phases after the
injection of 123I-MIBG at a dose of 147.3 ± 2.9 MBq. The
injection dose was measured in the glass syringe. The matrix
was 256 9 256 in patient imaging, and other imaging param-
eters were the same as the point-source imaging described
above.
Late images were acquired successively with three
different collimators in each patient. The subjects were divided
into two groups: groups A (n = 20) and B (n = 20). In group
A, the LEAP and SLEHR collimators were used in addition to
the ME collimator. Ten patients were imaged with the LEAP,
ME, and SLEHR collimators, in that order, and the remaining
10 patients were imaged in the reverse order. In group B, the
LME and CHR collimators were used in addition to the ME
collimator. Ten patients were imaged with the LME, ME, and
CHR collimators, in that order, and the remaining 10 patients
in the reverse order. In both groups, the first, second, and third
imagings were started approximately 3 h 50 min, 4 h, and
Table 1. Specifications of the collimators
Vendor Collimator Hole length (mm) Hole diameter (mm) Septal thickness (mm)
Siemens LEHR 24.05 1.11 0.16
Siemens LEAP 24.05 1.45 0.20
Siemens SLEHR 40.00 1.90 0.25
Siemens LME 37.00 2.50 0.60
Siemens ME 40.64 2.94 1.14
Philips CHR 48.00 2.03 0.152
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4 h 10 min after injection, respectively. Patients lay still on the
imaging table during the collimator change for successive
imagings with the Siemens camera, and moved to the next
room for imaging with different cameras. Patients were not
imaged with the LEHR collimator, and the conversion equa-
tions reported previously8 were used for analysis.
Calculation of H/M Ratios
In processing of the Siemens camera images, ROIs for the
heart and upper mediastinum were placed on the photopeak
image obtained with the ME collimator and were copied onto
other images. An irregular-shaped heart ROI was drawn
manually over the left ventricle. The mediastinum ROI was set
by a semiautomated method. The operator placed a rectangular
preliminary ROI of 25 9 30 pixels to include the low-count
area of the upper mediastinum. Then, the position of the final
rectangular ROI of 12 9 20 pixels was determined automat-
ically within the preliminary ROI to minimize the mean count
in the final ROI. In processing of the Philips camera images,
heart ROIs were drawn manually, visually referring to the
ROIs drawn on the Siemens camera images of the same
patient. The sizes of the preliminary and final ROIs were
changed to 26 9 31 and 12 9 21 pixels, respectively, to
compensate for the differences in pixel size between the two
cameras. The H/M ratio, the ratio of the mean count density in
the heart ROI to the mean count density in the mediastinum
ROI, was calculated before and after IDW correction. The
uncorrected H/M ratio measured with the ME collimator was
regarded as a standard value.
Determination of Conversion Equations
Based on the results of patient imaging, we determined
the equations to convert the H/M ratios measured with the non-
ME collimators to ME-based equivalent values (patient-based
conversion equations). The standard values, i.e., uncorrected
H/M ratios obtained with the ME collimator, were plotted
against the ratios obtained with another collimator before and
after IDW correction, and linear regression analysis was
performed to determine the conversion equations for empiric
correction and combined correction (combination of IDW
correction and empiric correction), respectively.
Next, we investigated the methods to predict the conver-
sion equations for empiric and combined corrections based on
point-source data (point-source-based conversion equations).
Regarding empiric correction, we substituted 4 for the ME-
based equivalent value in the patient-based conversion equa-
tion for empiric correction, to calculate the uncorrected H/M
ratio equivalent to the ME-based value of 4 (uncorrected 4-
equivalent) for each collimator. If the equation to convert a
non-ME-based H/M ratio (x) to an ME-based value (y) was
y = ax ? b (a and b are constants), we substituted 4 for y and
calculated the 4-equivalent as (4 - b)/a. For the LEHR
collimator, the conversion equation reported previously were
used.8 The uncorrected 4-equivalents with various collimators
were plotted against the uncorrected central ratios, and
monoexponential curve fitting was performed to determine
the equation to predict the uncorrected 4-equivalents from the
uncorrected central ratio. Similarly, uncorrected H/M ratio
equivalent to the ME-based value of 1 (uncorrected 1-equiv-
alent) was calculated, and the equation to predict the
uncorrected 1-equivalent from the uncorrected central ratio
was determined. To predict the point-source-based conversion
equation for empiric correction for a collimator, the uncor-
rected 4-equivalent and uncorrected 1-equivalent were
calculated by substituting the uncorrected central ratio of the
collimator in the monoexponential equations. Assuming the
linear relationship between the ME-based and non-ME-based
H/M ratios, the conversion equation was defined as follows:
y ¼ 3
E4  E1 xþ
E4  4E1
E4  E1 ; ð2Þ
where E4 and E1 are the 4-equivalent and 1-equivalent,
respectively.
In predicting the conversion equations for combined
correction, the patient-based conversion equations for combined
correction were used to calculate the IDW-corrected 4-equiv-
alents and 1-equivalents. They were compared with the IDW-
corrected central ratios, instead of the uncorrected central ratios.
The patient-based empiric correction, patient-based com-
bined correction, point-source-based empiric correction, and
point-source-based combined correction were applied to the
patient imaging data obtained with the non-ME collimators.
For empiric and combined corrections, the uncorrected and
IDW-corrected H/M ratios measured with various collimators
were substituted in the conversion equations, respectively. The
non-ME-derived H/M ratios determined before and after
correction were compared with the standard values by linear
regression. The error was calculated as the non-ME-derived H/
M ratio minus the standard value.
Statistical Analysis
Values are expressed as mean ± SD. Linear regression
analysis was performed using the least-squares method to
assess the relationships between two variables. The absolute
values of the errors were compared by paired t test between
empiric and combined corrections. A P value less than 0.05
was deemed to indicate statistical significance.
RESULTS
Point-source imaging demonstrated counts in the
peripheral regions of the field-of-view, distant from the
point source, to various degrees depending on the
collimators. The central ratio before IDW correction was
the largest for the ME collimator, representing the least
septal penetration, followed by the LME, SLEHR,
LEAP, CHR, and LEHR collimators (Table 2). The
IDW correction resulted in increases in the central
ratios.
In patient imaging, underestimation of the H/M
ratio was demonstrated for the non-ME collimators with
no correction applied (Figures 1 and 2). The
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underestimation was more severe in patients with larger
H/M ratios and small with the LME collimator. The
mean H/M ratios were 2.18 ± 0.91, 1.71 ± 0.46, and
1.79 ± 0.54 with the ME, LEAP, and SLEHR collima-
tors, respectively, in group A, and 2.07 ± 0.92,
1.96 ± 0.78, and 1.63 ± 0.44 with the ME, LME, and
CHR collimators, respectively, in group B. The mean
error was negative (Table 3). The underestimation was
less severe for the LME collimator than for the other
non-ME collimators.
The patient-based conversion equations for empiric
and combined corrections are presented in Table 4.
These equations were used to calculate the uncorrected
and IDW-corrected 4-equivalents and 1-equivalents for
non-ME collimators. Regarding the ME collimator, the
equation y = x was assumed for empiric correction, and
the equation y = 0.920x ? 0.097, determined from
comparison between uncorrected and IDW-corrected
ME-derived H/M ratios in group A, was used. The
resulting uncorrected and IDW-corrected 4-equivalents
increased with increasing uncorrected and IDW-cor-
rected central ratios, respectively (Figure 3), and the
monoexponential curve fitting was successful. The 1-
equivalents were close to 1.
The uncorrected 4-equivalents and 1-equivalents
were predicted from the equations in Figure 3A and the
uncorrected central ratios, and the point-source-based
conversion equations for empiric correction were deter-
mined (Table 4). The IDW-corrected 4-equivalents and
1-equivalents were predicted from the regression equa-
tions in Figure 3B and the IDW-corrected central ratios,
and the point-source-based conversion equations for
combined correction were determined (Table 4).
Corrections using the patient-based conversion
equations effectively reduced collimator-dependent dif-
ferences in the H/M ratios (Figures 1 and 2). Naturally,
the systematic underestimation was removed, as indi-
cated by the mean errors of zero (Table 3). After empiric
correction, the SD of the error, representing residual
random errors, was the largest for the CHR collimators,
followed by the LEAP, SLEHR, and LME collimators.
Combined correction mildly reduced the SD of the error
for the LEAP, SLEHR, and CHR collimators when
compared with empiric correction. For these three
collimators, absolute values of the errors were signifi-
cantly smaller after combined correction (LEAP,
0.06 ± 0.05; SLEHR, 0.06 ± 0.06; LME, 0.06 ± 0.05;
CHR, 0.09 ± 0.06) than after empiric correction (LEAP,
0.12 ± 0.08, P\ .001; SLEHR, 0.09 ± 0.08, P\ .01;
LME, 0.06 ± 0.04, P = .768; CHR, 0.14 ± 0.07,
P\ .05).
Point-source-based empiric and combined correc-
tions also yielded successful results (Figures 4 and 5).
The mean errors ranged from -0.01 to 0.04 for empiric
correction and from -0.01 to 0.01 for combined
correction, indicating almost complete removal of sys-
tematic underestimation (Table 3). The SD of the error
was almost identical between patient-based and point-
source-based correction.
DISCUSSION
In this study, we imaged the same patients succes-
sively with ME and various non-ME collimators, and
calculated the H/M ratios. Using the results, we inves-
tigated generally applicable methods for estimating the
H/M ratio to be obtained with the ME collimator from
the images acquired with a non-ME collimator. System-
atic underestimation of the H/M ratio, attributable to
septal penetration, was confirmed for various non-ME
collimators. More severe underestimation in patients
with larger H/M ratios would disturb the assessment of
the presence and severity of cardiac sympathetic func-
tion.7-9 Additionally, the intensity and distribution of
123I-MIBG activity in the lung and liver affect the
degree of underestimation;4,9 and therefore, the non-
ME-derived H/M ratios would reflect cardiac sympa-
thetic function less faithfully than ME-derived values.
The ME collimator is less susceptible to septal penetra-
tion and is recommended for estimation of the H/M
ratio.4-6 However, when the ME collimator is not
available, the conversion of non-ME-derived H/M ratios
to ME-based values would be beneficial to facilitate
comparisons of values obtained with different
collimators.
In empiric correction, the H/M ratios obtained with
a non-ME collimator are substituted in the conversion
equation determined empirically to yield ME-based
equivalent values. We determined the equations to
convert non-ME-derived values to ME-based values by
intrapatient comparisons of the ME-derived and non-
ME-derived H/M ratios. Empiric correction removes
Table 2. Central ratios obtained by point-source
imaging







IDW (-) and IDW (?) indicate data before and after IDW
correction, respectively
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systematic underestimation due to septal penetration;
however, it does not reduce random errors.
The IDW method estimates the influence of septal
penetration from images acquired in the high-energy
subwindow. Although systematic errors in the H/M
ratios remained after IDW correction alone in previous
studies,7,8 the subwindow images reflect the patient-by-
patient differences in the influence of penetration of
high-energy photons; thus, the IDW correction has the
potential to reduce not only systematic underestimation
but also random errors. In combined correction, the
IDW-corrected H/M ratios are converted to ME-based
equivalent values using an empiric equation. The
first step (IDW correction) decreases systematic
Figure 1. Patient-based correction of the H/M ratios obtained with non-ME (A, LEAP; B, SLEHR;
C, LME; D, CHR) collimators. The values before correction (green square), after empiric
correction (blue circle), and after combined correction (red triangle) were plotted against the
uncorrected values obtained with the ME collimator. The broken line indicates the line of identity.
Results of linear regression are shown.
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underestimation and random errors, and then the second
step (empiric correction) removes the remaining sys-
tematic underestimation. Superiority of this combination
strategy to pure empiric correction was demonstrated for
the LEHR collimator in a previous study8 and for the
LEAP, SLEHR, and CHR collimators in the present
study. The differences in residual errors between
empiric and combined corrections were small for these
three collimators, presumably because errors after
empiric correction were small. However, the differences
in operator’s burden for data processing are also small.
We recommend the use of combined correction rather
than pure empiric correction when counts in the same
subwindow as that set in the present study are available.
For the LME collimator, the combined correction did
not provide additional benefit over the empiric
Figure 2. Errors before and after patient-based correction (A, LEAP; B, SLEHR; C, LME;
D, CHR). Errors before correction (green square), after empiric correction (blue circle), and after
combined correction (red triangle) were plotted against the uncorrected H/M ratios obtained with
the ME collimator. Results of linear regression are shown.
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correction, presumably because the underestimation
with no correction was small and uncertainty in IDW
correction canceled the potential minor benefit.
The conversion equations were established based on
intrapatient comparison for five collimators as presented
in Table 4. To predict the conversion equations for other
Figure 3. Central ratios and H/M ratios equivalent to the ME-based values of 4 (closed circle) and 1 (open
circle) before (A) and after (B) IDW correction. Results of monoexponential curve fitting are shown.




Empiric Combined Empiric Combined
LEHR y = 2.157x - 1.235 y = 1.428x - 0.453 y = 2.310x - 1.523 y = 1.438x - 0.490
LEAP y = 1.943x - 1.143 y = 1.296x - 0.360 y = 1.876x - 1.019 y = 1.269x - 0.301
SLEHR y = 1.668x - 0.803 y = 1.105x - 0.141 y = 1.615x - 0.719 y = 1.089x - 0.102
LME y = 1.169x - 0.221 y = 0.976x ? 0.020 y = 1.162x - 0.203 y = 0.967x ? 0.031
CHR y = 2.047x - 1.276 y = 1.225x - 0.244 y = 2.018x - 1.184 y = 1.253x - 0.284
The patient-based equations for the LEHR collimator are cited from Reference8




Patient-based correction Point-source-based correction
Empiric Combined Empiric Combined
LEAP -0.47 ± 0.46 0.00 ± 0.14 0.00 ± 0.08 0.01 ± 0.15 0.00 ± 0.09
SLEHR -0.39 ± 0.38 0.00 ± 0.12 0.00 ± 0.09 -0.01 ± 0.12 0.00 ± 0.09
LME -0.11 ± 0.15 0.00 ± 0.07 0.00 ± 0.08 0.00 ± 0.07 -0.01 ± 0.08
CHR -0.43 ± 0.49 0.00 ± 0.16 0.00 ± 0.11 0.04 ± 0.16 0.01 ± 0.11
Values are mean ± SD
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collimators without additional intrapatient comparison,
we investigated the relationship between the conversion
equation and simple index reflecting the physical char-
acteristics of the collimator. For convenience, point-
source imaging was employed to assess the degree of
septal penetration. The central ratio proposed here
reflects counts associated with septal penetration, and
its small value indicates that an image obtained with the
collimator is highly susceptible to penetration. The H/M
ratios equivalent to the ME-based value of 4, calculated
for various collimators using the patient-based conver-
sion equations, were strongly dependent on the central
ratios. One of the collimators examined was provided by
a vendor different from that for the other collimators;
however, that collimator did not produce an outlier in
the plots. Based on the relationship, the conversion
Figure 4. Point-source-based correction of the H/M ratios obtained with non-ME (A, LEAP; B,
SLEHR; C, LME; D, CHR) collimators. The values after empiric correction (blue circle) and after
combined correction (red triangle) were plotted against the uncorrected values obtained with the
ME collimator. The broken line indicates the line of identity. Results of linear regression are shown.
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equation was predicted from the central ratio. The
application of correction using the point-source-based
conversion equations achieved successful correction.
The IDW-corrected central ratio appears to represent the
influence of penetration on IDW-corrected patient
images, and was used to predict the conversion equation
for combined correction. Our point-source-based
method of predicting conversion equations is easily
feasible and permits correction of the H/M ratio with
almost the same accuracy as patient-based correction. It
appears to be valuable for enhancing the applicability of
correction of collimator-dependent differences.
Point-source imaging to define the central ratios is
quite simple; however, the imaging conditions should be
the same as those used in the present study to apply the
presented equations. Particularly, the importance of the
source-collimator geometry appears to deserve special
emphasis. When septal penetration is negligible, the
distance affects spatial resolution, but its influence on
counting sensitivity is limited. However, in imaging 123I
Figure 5. Errors after point-source-based correction (A, LEAP; B, SLEHR; C, LME; D, CHR)
collimators. Errors after empiric correction (blue circle) and combined correction (red triangle)
were plotted against the uncorrected H/M ratios obtained with the ME collimator. Results of linear
regression are shown.
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with the non-ME collimator, the contribution of high-
energy photons decreases at a larger distance, apparently
reducing the counting sensitivity.14 Off-center position-
ing of the point source may also affect the estimation of
the central ratios through varying counts in the periph-
eral region. It should be noted that the assessment of
septal penetration is vulnerable to variations in the
imaging conditions.
We summarize the strategy to correct collimator-
dependent differences in the H/M ratio. If cardiac 123I-
MIBG imaging is performed with one of the non-ME
collimators described in Table 4, the patient-based con-
version equation will be used. Combined correction is
recommended for the Siemens LEHR, Siemens LEAP,
Siemens SLEHR, and Philips CHR collimators if appro-
priate subwindow data are available, and empiric
correction suffices for the Siemens LME collimator. For
other collimators, the point-source-based conversion
equations should be determined. First, point-source
imaging is performed to measure the central ratio. If
combined correction is planned, the IDW-corrected
central ratio is substituted in the equations
y = 1.5961 9 e1.0059x and y = 1.1233 9 e-0.1215x to cal
culate the IDW-corrected H/M ratios equivalent to the
ME-based values of 4 (E4) and 1 (E1), respectively. If
empiric correction is planned, the uncorrected central
ratio is substituted in the equations y = 1.3980 9 e1.1278x
and y = 1.1715 9 e-0.1468x to calculate the uncorrected
H/M ratios equivalent to ME-based values of 4 and 1,
respectively. The point-source-based conversion equation
is determined as Eq. [2].
The use of an ME collimator is recommendable in
cardiac 123I-MIBG imaging because it provides more
accurate H/M ratios and also offers better SPECT
images compared with an LEHR collimator.15 If an ME
collimator is not available, a collimator with the least
penetration in the facility may be used for imaging,
followed by conversion to an ME-based equivalent
value. The ME-based values cannot be compared
directly with the cutoff values used in current clinical
practice because the cutoff values appear to be deter-
mined from LE-based H/M ratios. Actually, the H/M
ratios are supposed to have been obtained with various
collimators provided by various vendors, resulting in
various degrees of underestimation. To determine a new
ME-based cutoff value, additional clinical trials are not
needed. H/M ratios obtained in the previous studies can
be easily converted to ME-based values by empiric
correction using conversion equations determined for
the respective collimators. Residual random errors after
empiric correction would not cause substantial problems
in determining a new cut-off value from group analysis.
NEW KNOWLEDGE GAINED
The conversion equations for empiric correction
and combined correction determined based on patient
data are presented to convert the H/M ratios obtained
with various non-ME collimators to ME-based equiva-
lent values. Combined correction, a combination of
empiric correction and IDW correction, generally pro-
vides better accuracy than pure empiric correction. The
conversion equations can be predicted from simple
point-source imaging without patient imaging.
CONCLUSIONS
In this study, we compared the H/M ratios obtained
with various non-ME collimators with those obtained
with the ME collimator, and determined conversion
equations to correct collimator-dependent differences in
the estimates of the H/M ratios. Underestimation of the
H/M ratio, attributable to septal penetration, was
confirmed for the non-ME collimators. Empiric correc-
tion using the patient-based conversion equations
removed systematic underestimation, and the combined
method of the empiric and IDW corrections depressed
residual random errors, achieving more accurate cor-
rection to some degree. The conversion equations for
empiric and combined corrections can be predicted
from simple point-source imaging, which enhances the
applicability of the correction methods. Although the
use of the ME collimator is preferable, the correction
of collimator-dependent differences presented here
is expected to improve the usefulness of cardiac
123I-MIBG imaging.
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